BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31210946)

  • 21. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
    Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
    Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is endoscopic ultrasound "sound" for pancreatic cancer screening?
    Bhutani MS; Verma D; Guha S; Lee JH; Richards-Kortum RR; Fleming JB
    J Clin Gastroenterol; 2009 Oct; 43(9):797-802. PubMed ID: 19652621
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevalence and outcomes of pancreatic cystic neoplasms in liver transplant recipients.
    Liu K; Joshi V; van Camp L; Yang QW; Baars JE; Strasser SI; McCaughan GW; Majumdar A; Saxena P; Kaffes AJ
    World J Gastroenterol; 2017 Dec; 23(48):8526-8532. PubMed ID: 29358860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance.
    Konings IC; Harinck F; Kuenen MA; Sidharta GN; Kieffer JM; Aalfs CM; Poley JW; Smets EM; Wagner A; van Rens A; Vleggaar FP; Ausems MG; Fockens P; van Hooft JE; Bruno MJ; Bleiker EM;
    Fam Cancer; 2017 Jan; 16(1):143-151. PubMed ID: 27629874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging Follow-up of Low-Risk Incidental Pancreas and Kidney Findings: Effects of Patient Age and Comorbidity on Projected Life Expectancy.
    Raphel TJ; Weaver DT; Berland LL; Herts BR; Megibow AJ; Knudsen AB; Pandharipande PV
    Radiology; 2018 May; 287(2):504-514. PubMed ID: 29401040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma.
    Park HJ; Jang KM; Song KD; Kim SH; Kim YK; Cha MJ; Choi SY; Min K
    Clin Radiol; 2017 Dec; 72(12):1076-1084. PubMed ID: 28784320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraductal papillary mucinous neoplasm of the main duct in a patient with pancreas divisum.
    Sánchez Acedo P; Viteri Ramírez G; Herrera Cabezón J; Tarifa Castilla A
    Rev Esp Enferm Dig; 2019 Apr; 111(4):322. PubMed ID: 30746953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics.
    Verna EC; Hwang C; Stevens PD; Rotterdam H; Stavropoulos SN; Sy CD; Prince MA; Chung WK; Fine RL; Chabot JA; Frucht H
    Clin Cancer Res; 2010 Oct; 16(20):5028-37. PubMed ID: 20876795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystic pancreatic lesions: From increased diagnosis rate to new dilemmas.
    Nougaret S; Mannelli L; Pierredon MA; Schembri V; Guiu B
    Diagn Interv Imaging; 2016 Dec; 97(12):1275-1285. PubMed ID: 27840080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
    Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
    Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individuals.
    Levink IJM; Klatte DCF; Hanna-Sawires RG; Vreeker GCM; Ibrahim IS; van der Burgt YEM; Overbeek KA; Koopmann BDM; Cahen DL; Fuhler GM; Wuhrer M; Bonsing BA; Tollenaar RAEM; Vleggaar FP; Vasen HFA; van Leerdam ME; Bruno MJ; Mesker WE
    Pancreatology; 2022 May; 22(4):497-506. PubMed ID: 35414481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refinement of screening for familial pancreatic cancer.
    Bartsch DK; Slater EP; Carrato A; Ibrahim IS; Guillen-Ponce C; Vasen HF; Matthäi E; Earl J; Jendryschek FS; Figiel J; Steinkamp M; Ramaswamy A; Vázquez-Sequeiros E; Muñoz-Beltran M; Montans J; Mocci E; Bonsing BA; Wasser M; Klöppel G; Langer P; Fendrich V; Gress TM
    Gut; 2016 Aug; 65(8):1314-21. PubMed ID: 27222532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency and Outcomes of Incidental Breast Lesions Detected on Abdominal MRI Over a 7-Year Period.
    Prabhu V; Chhor CM; Ego-Osuala IO; Xiao JM; Hindman NM; Rosenkrantz AB
    AJR Am J Roentgenol; 2017 Jan; 208(1):107-113. PubMed ID: 27809561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between hyperechogenic pancreas and pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasms.
    Mandai K; Uno K; Nakase K; Kawamura T; Yasuda K
    J Med Ultrason (2001); 2019 Oct; 46(4):435-439. PubMed ID: 31069577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry.
    Del Chiaro M; Zerbi A; Capurso G; Zamboni G; Maisonneuve P; Presciuttini S; Arcidiacono PG; Calculli L; Falconi M;
    Dig Liver Dis; 2010 Sep; 42(9):597-605. PubMed ID: 20627831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of genetic risk for pancreatic adenocarcinoma.
    Flores K; Dinh K; Rouleau E; Whalen G; Wassef W; LaFemina J
    Cancer Genet; 2015 Nov; 208(11):559-63. PubMed ID: 26481832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging.
    Jang KM; Kim SH; Kim YK; Song KD; Lee SJ; Choi D
    Eur J Radiol; 2015 Aug; 84(8):1473-1479. PubMed ID: 26032128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Standardization of MRI Screening and Reporting in Individuals With Elevated Risk of Pancreatic Ductal Adenocarcinoma: Consensus Statement of the PRECEDE Consortium.
    Huang C; Simeone DM; Luk L; Hecht EM; Khatri G; Kambadakone A; Chandarana H; Ream JM; Everett JN; Guimaraes A; Liau J; Dasyam AK; Harmath C; Megibow AJ;
    AJR Am J Roentgenol; 2022 Dec; 219(6):903-914. PubMed ID: 35856454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).
    Vasen HF; Gruis NA; Frants RR; van Der Velden PA; Hille ET; Bergman W
    Int J Cancer; 2000 Sep; 87(6):809-11. PubMed ID: 10956390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic cysts: What imaging characteristics are associated with development of pancreatic ductal adenocarcinoma?
    Paroder V; Flusberg M; Kobi M; Rozenblit AM; Chernyak V
    Eur J Radiol; 2016 Sep; 85(9):1622-6. PubMed ID: 27501898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.